Clinical trial Recruiting at 1 site Observational Ages 50 to 75

Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

Official title: Association Between Sarcopenia and Outcomes of Interlaminar Epidural Steroid Injection in Patients With Lumbar Spinal Stenosis: A Prospective Observational Study

Run by Marmara University · NCT07855419 · Data updated 2026-11-12

We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

Quick facts

Study typeObservational
Ages50 Years to 75 Years
SexAll
Enrollment70 (estimated)
SponsorMarmara University
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedOctober 2, 2026
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07855419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50–75 with clinically and radiologically confirmed lumbar spinal stenosis who are scheduled for an interlaminar epidural steroid injection and have MRI data available.

Probably not a fit

Patients without sarcopenia or with outcomes not influenced by muscle characteristics may not experience specific benefit from this observational assessment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will enroll patients with lumbar spinal stenosis who are planned to receive an interlaminar epidural steroid injection as part of standard care. Before the procedure, researchers will assess sarcopenia using the SARC-F questionnaire, handgrip strength, and the five-times sit-to-stand test, and will review lumbar MRI for paraspinal muscle characteristics and stenosis severity. Outcomes such as pain, functional status, walking ability, and health-related quality of life will be measured at baseline and then again at 3 weeks and 3 months post-injection to see if sarcopenia and muscle characteristics influence these results.

Why it matters

Potential benefit: If sarcopenia is linked to poorer outcomes, this could guide personalized care and rehabilitation strategies after injections.

How similar studies have gone: Prior studies in related contexts suggest muscle mass and function can affect outcomes after spine interventions, but this exact approach is relatively novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical and radiological diagnosis of lumbar spinal stenosis
* Persistent symptoms despite conservative treatment and scheduled to undergo interlaminar epidural steroid injection as part of routine clinical care
* Age between 50 and 75 years
* Low back and/or leg pain for at least 3 months
* Availability of lumbar magnetic resonance imaging (MRI)

Exclusion Criteria:

* History of lumbar fusion surgery
* Lumbar epidural steroid injection within the previous 3 months
* Prominent radiculopathy due to lumbar disc herniation
* Severe motor deficit or an indication for surgical treatment
* Polyneuropathy, neuromuscular disease, or neurological disease that may significantly affect muscle mass
* Active malignancy or systemic inflammatory disease
* Significant mobility limitation due to advanced hip or knee osteoarthritis
* Cognitive impairment or communication problems that may prevent completion of study assessments
* Coagulopathy or active infection constituting a contraindication to epidural injection
* Inflammatory rheumatic disease requiring chronic corticosteroid therapy

Where it's running

  • Marmara University Pendik Training and Research Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.